Abstract

In the setting of trauma with hemorrhagic shock, balanced blood product resuscitation requires transfusing a high ratio of plasma and platelets to red blood cells. Multiple units of blood products must be transfused rapidly, each product is separately packaged, and each product has a different volume, preparation method, shelf-life, and availability. Despite limited initial data comparing whole blood (WB) to blood component therapy (BCT), recent military medicine shows both a survival benefit and safety of warm WB transfusion over component therapy. This has sparked a renewed interest in the practice of using cold-stored type-O WB (CWB) for resuscitation of hemorrhagic shock in the civilian setting. While recent studies have demonstrated benefits and safety when comparing type-specific and type-O CWB verses component therapy, they have not evaluated the acute resuscitative period. The purpose of this study was to report the impact of CWB on initial resuscitation.

Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call